Announcement Expanding the Impact of Precision Medicine to Fuel Discoveries Thursday, February 12, 2015 Finding Clues in Genes of ‘Exceptional Responders’ Thursday, October 9, 2014 Event A Sneak Preview of Our Annual “Major Trends” Seminar Live Webcast Monday, November 3, 2014 Feature Memorial Sloan Kettering Transforms Cancer Research and Care Delivery Friday, July 11, 2014 Landmark $100 Million Gift from the Marie-Josée and Henry R. Kravis Foundation Supports a Groundbreaking Approach to Precision Oncology Sunday, June 1, 2014 Molecular-Based Treatment for Bladder Cancer Friday, May 23, 2014 Cancer ‘Miracle’ Patients Studied Anew for Disease Clues Friday, April 11, 2014 Announcement Bold Initiative to Transform Cancer Care Established with a $100 Million Gift Tuesday, May 20, 2014 Profile At Work: Physician-Scientist David Solit Tuesday, May 27, 2014 Seeking Medical Clues From the 'Super Responder' Monday, February 17, 2014 Looking for Lessons in Cancer's 'Miracle' Responders Sunday, September 15, 2013 In the Lab Study Clarifies How Bladder Cancer Treatment Works Friday, February 1, 2013 Feature Cancer Genomics: New Technologies Speed Discovery and Expand Opportunities for Personalized Medicine Monday, November 26, 2012 Feature Starr Foundation Renews Gifts for Cancer Consortium and Stem Cell Research Initiative Friday, June 1, 2012 Study Reveals How Some Skin Tumors May Evade New Therapy Thursday, March 1, 2012 Honors Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team” Wednesday, December 14, 2011 Media Advisory Researchers Discover Why New Melanoma Drug Stops Working Wednesday, November 23, 2011 Genome Sequencing Clears Up a Cancer Medical Mystery Thursday, August 23, 2012 In the Clinic Prestigious Grant Bolsters Bladder Cancer Research at MSK Friday, May 31, 2019 Book traversal links for The David Solit Lab Previous Whole Genome Sequencing of Outlier Responders to Systemic Cancer Therapies (Extraordinary Responder Initiative) Next Publications
Landmark $100 Million Gift from the Marie-Josée and Henry R. Kravis Foundation Supports a Groundbreaking Approach to Precision Oncology
